The Patent Finder

Green Cross Corporation

Also on record
Records under this name other than the patents Green Cross Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 40 patents it holds.

Back to Green Cross Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,524,054Method of treating anemia using long-acting EPO formulation
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 10,889,574Method for Producing Diphenylmethane Derivative
Held by another company
In force
 · Medium confidence
In forceMedium confidence
US 11,401,343Anti-Msln Antibody and Pharmaceutical Composition for Cancer Treatment Comprising Same
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,840,895Human Antibodies Specifically Binding to the Hepatitis B Virus Surface Antigen
Lapsed on the fee record
Ended Sep 23, 2026 · High confidence
Lapsed on the fee recordEnded Sep 23, 2026High confidence
US 11,447,559Anti-Bcma Antibody Having High Affinity for Bcma and Pharmaceutical Composition for Treatment of Cancer, Comprising Same
Formerly held
Lapsed on the fee record
Ended Sep 20, 2026 · High confidence
Lapsed on the fee recordEnded Sep 20, 2026High confidence
US 8,748,175Antibodies specifically binding to the epidermal growth factor receptor
Lapsed on the fee record
Ended Jun 10, 2026 · USPTO record
Lapsed on the fee recordEnded Jun 10, 2026USPTO record
US 11,332,528Anti-CEACAM1 antibody and use thereof
Lapsed on the fee record
Ended May 17, 2026 · USPTO record
Lapsed on the fee recordEnded May 17, 2026USPTO record
US 11,198,733Pharmaceutical composition for inhibiting metastasis of cancer, comprising, as active ingredient, antibody that specifically binds to epidermal growth factor receptor
Lapsed on the fee record
Ended Dec 14, 2025 · USPTO record
Lapsed on the fee recordEnded Dec 14, 2025USPTO record
US 9,683,029Antibody composition for prevention or treatment of mutant hepatitis B virus infection
Lapsed on the fee record
Ended Jun 20, 2025 · USPTO record
Lapsed on the fee recordEnded Jun 20, 2025USPTO record
US 10,918,717Pharmaceutical formulation comprising anti-EGFR antibody
Lapsed on the fee record
Ended Feb 16, 2025 · USPTO record
Lapsed on the fee recordEnded Feb 16, 2025USPTO record
10 of 249 patents shown.
Pro members see all 249.
Pro members: see all 249 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited